title: Hypothalamic paraventricular nucleus, but not vasopressin, participates in chronic hyperactivity of the HPA axis in diabetic rats.
abstract: Diabetes mellitus (DM), as chronic stress activates the hypothalamo-pituitary-adrenocortical axis. We examined whether arginine vasopressin (AVP) and the hypothalamic paraventricular nucleus (PVN) participate in DM-induced chronic stress symptoms. AVP-deficient Brattleboro or PVN-lesioned Wistar rats were used with heterozygous or sham-operated controls. The rats were studied 2 wk after a single injection of streptozotocin. The appearance of DM (enhanced water consumption and blood glucose elevation) and the chronic stress-like somatic changes (body weight decrease, thymus involution, adrenal gland hypertrophy) were not influenced by the lack of AVP. By contrast, PVN lesion significantly attenuated DM-induced thymus involution and adrenal gland hypertrophy as well as the increase in water consumption. The corticotropin-releasing hormone mRNA in PVN was diminished by DM and elevated by the lack of AVP without interaction. DM elevated the proopiomelanocortin (POMC) mRNA in the anterior lobe of the pituitary. The lack of AVP had no effect, whereas lesioning the PVN significantly diminished the elevation. The elevated basal corticosterone plasma levels detectable in DM were influenced neither by the lack of AVP nor by lesioning the PVN. Thus the lack of AVP had no influence on DM-induced chronic stress symptoms, but lesioning the PVN attenuated part of them. However, the lack of elevation in POMC mRNA after PVN lesion, together with the maintained corticosterone elevation, suggests that direct adrenal gland activation occurs in untreated DM.
authors.affiliation: Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Szigony 43, Hungary. zelena@koki.hu
authors.forename: Dóra
authors.initials: D
authors.lastname: Zelena
authors.forename: Ludmila
authors.initials: L
authors.lastname: Filaretova
authors.forename: Zsuzsa
authors.initials: Z
authors.lastname: Mergl
authors.forename: István
authors.initials: I
authors.lastname: Barna
authors.forename: Zsuzsanna E
authors.initials: ZE
authors.lastname: Tóth
authors.forename: Gábor B
authors.initials: GB
authors.lastname: Makara
mesh_terms: D000818:Animals; D001127:Arginine Vasopressin / Q000378:metabolism*; D002908:Chronic Disease; D003921:Diabetes Mellitus, Experimental / Q000139:chemically induced / Q000150:complications / Q000503:physiopathology*; D004700:Endocrine System Diseases / Q000209:etiology / Q000503:physiopathology*; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology*; D008297:Male; D010286:Paraventricular Hypothalamic Nucleus / Q000503:physiopathology*; D010913:Pituitary-Adrenal System / Q000503:physiopathology*; D051381:Rats; D011910:Rats, Brattleboro; D017208:Rats, Wistar
chemical_list: D001127:Arginine Vasopressin